- Home
- VKTX vs HQY Comparison
VKTX vs HQY Comparison
Compare VKTX & HQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKTX
- HQY
- Stock Information
- Founded
- VKTX 2012
- HQY 2002
- Country
- VKTX United States
- HQY United States
- Employees
- VKTX N/A
- HQY N/A
- Industry
- VKTX Biotechnology: Pharmaceutical Preparations
- HQY Business Services
- Sector
- VKTX Health Care
- HQY Consumer Discretionary
- Exchange
- VKTX Nasdaq
- HQY Nasdaq
- Market Cap
- VKTX 7.2B
- HQY 8.5B
- IPO Year
- VKTX 2015
- HQY 2014
- Fundamental
- Price
- VKTX $49.58
- HQY $98.98
- Analyst Decision
- VKTX Strong Buy
- HQY Buy
- Analyst Count
- VKTX 10
- HQY 12
- Target Price
- VKTX $109.80
- HQY $107.50
- AVG Volume (30 Days)
- VKTX 6.8M
- HQY 666.1K
- Earning Date
- VKTX 10-23-2024
- HQY 12-09-2024
- Dividend Yield
- VKTX N/A
- HQY N/A
- EPS Growth
- VKTX N/A
- HQY 694.69
- EPS
- VKTX N/A
- HQY 1.20
- Revenue
- VKTX N/A
- HQY $1,099,131,000.00
- Revenue This Year
- VKTX N/A
- HQY $19.35
- Revenue Next Year
- VKTX N/A
- HQY $11.32
- P/E Ratio
- VKTX N/A
- HQY $82.52
- Revenue Growth
- VKTX N/A
- HQY 17.19
- 52 Week Low
- VKTX $10.51
- HQY $62.10
- 52 Week High
- VKTX $99.41
- HQY $101.17
- Technical
- Relative Strength Index (RSI)
- VKTX 31.07
- HQY 68.11
- Support Level
- VKTX $62.50
- HQY $94.32
- Resistance Level
- VKTX $70.41
- HQY $101.17
- Average True Range (ATR)
- VKTX 5.16
- HQY 2.94
- MACD
- VKTX -2.29
- HQY 0.47
- Stochastic Oscillator
- VKTX 1.99
- HQY 86.64
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
About HQY HealthEquity Inc.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.